N-acetylcysteine (NAC) downregulates type I insulin-like growth factor receptor (IGF-IR) and epidermal growth factor receptor (EGFR) on colorectal carcinoma cell lines  possible mechanism underlying NAC-mediated chemoprevention and chemotherapy

Kenneth Nally

doi:10.1055/s-2005-922889

N-acetylcysteine (NAC) downregulates type I insulin-like growth factor receptor (IGF-IR) and epidermal growth factor receptor (EGFR) on colorectal carcinoma cell lines possible mechanism underlying NAC-mediated chemoprevention and chemotherapy

Kenneth Nally

Research output: Contribution to journal › Article › peer-review

Original language	English
Journal	Endoscopy
DOIs	https://doi.org/10.1055/s-2005-922889
Publication status	Published - 2006

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

Keywords

Medicine
Epidermal growth factor receptor
Insulin-Like Growth Factor Receptor
Acetylcysteine
Cancer research
Insulin-like growth factor
Growth factor receptor inhibitor
Colorectal cancer
Growth factor
Epidermal growth factor
Chemotherapy
Growth factor receptor
Cetuximab
Receptor
Insulin-like growth factor 2 receptor
Internal medicine
Oncology
Endocrinology
Insulin-like growth factor 1 receptor
Cancer
Biology
Biochemistry
Antioxidant

Access to Document

10.1055/s-2005-922889

https://openalex.org/W2631349416Licence: CC BY-NC-ND

Cite this

@article{c2eea2c65ba24c2dbbb16c090f8e7d74,

title = "N-acetylcysteine (NAC) downregulates type I insulin-like growth factor receptor (IGF-IR) and epidermal growth factor receptor (EGFR) on colorectal carcinoma cell lines possible mechanism underlying NAC-mediated chemoprevention and chemotherapy",

keywords = "Medicine, Epidermal growth factor receptor, Insulin-Like Growth Factor Receptor, Acetylcysteine, Cancer research, Insulin-like growth factor, Growth factor receptor inhibitor, Colorectal cancer, Growth factor, Epidermal growth factor, Chemotherapy, Growth factor receptor, Cetuximab, Receptor, Insulin-like growth factor 2 receptor, Internal medicine, Oncology, Endocrinology, Insulin-like growth factor 1 receptor, Cancer, Biology, Biochemistry, Antioxidant",

author = "Kenneth Nally",

year = "2006",

doi = "10.1055/s-2005-922889",

language = "English",

journal = "Endoscopy",

issn = "0013-726X",

publisher = "Georg Thieme Verlag",

}

TY - JOUR

T1 - N-acetylcysteine (NAC) downregulates type I insulin-like growth factor receptor (IGF-IR) and epidermal growth factor receptor (EGFR) on colorectal carcinoma cell lines possible mechanism underlying NAC-mediated chemoprevention and chemotherapy

AU - Nally, Kenneth

PY - 2006

Y1 - 2006

KW - Medicine

KW - Epidermal growth factor receptor

KW - Insulin-Like Growth Factor Receptor

KW - Acetylcysteine

KW - Cancer research

KW - Insulin-like growth factor

KW - Growth factor receptor inhibitor

KW - Colorectal cancer

KW - Growth factor

KW - Epidermal growth factor

KW - Chemotherapy

KW - Growth factor receptor

KW - Cetuximab

KW - Receptor

KW - Insulin-like growth factor 2 receptor

KW - Internal medicine

KW - Oncology

KW - Endocrinology

KW - Insulin-like growth factor 1 receptor

KW - Cancer

KW - Biology

KW - Biochemistry

KW - Antioxidant

U2 - 10.1055/s-2005-922889

DO - 10.1055/s-2005-922889

M3 - Article

SN - 0013-726X

JO - Endoscopy

JF - Endoscopy

ER -